What Does Incyte (INCY) Medicare Deal Mean For Future Drug Pricing Risk?Simplywall·1 day ago, 08:32 PMINCY-0.98%
Incyte (INCY) Stock Could Be 31% Stretched Following KRAS Data BuzzSimplywall·Aug 30 at 08:32 AMINCY-0.98%RVMD-0.40%
Incyte Corp. Stock Underperforms Friday When Compared To CompetitorsMarketWatch Automated·Aug 28 at 09:01 PMINCY-0.98%
Incyte Corp. Stock Underperforms Wednesday When Compared To CompetitorsMarketWatch Automated·Aug 26 at 09:03 PMINCY-0.98%
Incyte Corp. Stock Underperforms Tuesday When Compared To Competitors Despite Daily GainsMarketWatch Automated·Aug 25 at 09:03 PMINCY-0.98%
The Fragmentation of the Value Chain: What 'Uncategorized' Stocks Tell Us About Structural UnbundlingGlobal Report·Aug 25 at 11:33 AMSPIR+0.84%ENS+1.07%
Logitech Supply Risks Loom as ZJLD Bucks Trend in Diversified AssetsGlobal Report·Aug 25 at 09:20 AMLOGI+0.33%09878-1.69%
Wealthfront Advisers LLC Buys Shares of 9,753 Incyte Corporation $INCYMarket Beat·Aug 22 at 09:20 AMINCY-0.98%
Here’s How Much You Would Have Made Owning Incyte Stock In The Last 20 Yearsbenzinga_article·Aug 20 at 11:30 PMINCY-0.98%
Incyte President, Global Head of R&D Pablo J. Cagnoni sells 10,801 shares for $1.36 millionPUBT·Aug 20 at 09:16 PMINCY-0.98%
Incyte Corp. Stock Underperforms Wednesday When Compared To Competitors Despite Daily GainsMarketWatch Automated·Aug 19 at 09:02 PMINCY-0.98%
